Neonatal CLABSI Reduction Strategy (NCRS)
CLABSI (Central line-associated bloodstream infections) are one of the most common healthcare-associated infections in neonatal intensive care units. It is a significant concern leading to increased morbidity, mortality, neurodevelopmental outcomes, and healthcare costs. In Saudi Arabia, the current rate of neonatal CLABSI is 3.7/1000 central line days. Factors that increase the risk for CLABSI include intrinsic factors, such as immunologic immaturity and poor skin integrity, and extrinsic factors, such as frequent and prolonged catheter use, and frequent catheter manipulation associated with the need for medication and total parenteral nutrition. Clinical decisions that can potentially increase or decrease the risk for CLABSI (e.g., the choice of central line type or insertion site, the timing of catheter removal or replacement).
Vision
Mission
Aim
Strategic Goals
- Increase compliance with evidence-based infection prevention protocols and bundles.
- Improve staff knowledge and awareness regarding CLABSI prevention and guidelines.
- Enhance communication and collaboration among healthcare providers to ensure consistent adherence to infection control measures.
Neonatal CLABSI Reduction Strategy Components:
- Leadership support
- Availability of Supplies
- Infrastructure of NICUs
- CLABSI surveillance
- Training and education
- CLABSI prevention best practices
- Human Resources
- Communication and collaboration
- Competition NCRS
- Performance monitoring, evaluation & improvement
© All Rights Reserved For IPCKSA © 1443 – 2022